Keyphrases
Induced Apoptosis
100%
Reactive Oxygen Species
100%
Methotrexate
100%
Low-dose Methotrexate
100%
Monocytic
100%
Apoptosis
50%
Jurkat
50%
Reactive Oxygen Species Production
50%
Cytotoxicity
33%
Granularity
33%
T Cell Lines
33%
Methotrexate Treatment
33%
N-acetylcysteine
33%
Apoptotic Induction
33%
T Cells
16%
Cell Proliferation
16%
Hyperpolarization
16%
Oxidative Stress
16%
High Susceptibility
16%
Possible Mechanisms
16%
Beneficial Effects
16%
Antioxidant
16%
Cell Viability
16%
Rheumatoid Arthritis Patients
16%
Rheumatoid Arthritis
16%
Morphological Changes
16%
Anti-inflammatory Effect
16%
Apoptosis Induction
16%
Cell Size
16%
Side Scatter
16%
Reduced Cell
16%
Monocytic Cells
16%
THP1
16%
Immunomodulatory Effect
16%
U937
16%
Annexin V
16%
Annexin V Binding
16%
Mitochondrial Reactive Oxygen Species (mtROS)
16%
Forward Scattering
16%
Hyperproliferation
16%
R123
16%
Optimal Concentration
16%
Trypan Blue Assay
16%
MTT Test
16%
Raji B Cells
16%
Medicine and Dentistry
Low Drug Dose
100%
Programmed Cell Death
100%
Reactive Oxygen Species
100%
Lymphocyte
100%
Cell Line
100%
Methotrexate
100%
T Cell
30%
Cysteine
20%
Lipocortin 5
20%
Rheumatoid Arthritis
20%
Acetic Acid Derivative
20%
Cytotoxicity
20%
Morphology
10%
U937 Cell
10%
Cell Viability
10%
Cell Proliferation
10%
Antioxidant
10%
Anti-Inflammatory Drug
10%
Oxidative Stress
10%
Cell Size
10%
Dihydrorhodamine 123
10%
Immunosuppressive Drug
10%
Trypan Blue
10%
Immunology and Microbiology
Lymphocyte
100%
Cell Line
100%
Low Drug Dose
100%
Methotrexate
100%
T Cell
30%
Inflammatory Arthritis
20%
Cytotoxicity
20%
Immunosuppressive Drug
10%
Cell Proliferation
10%
Morphology
10%
Cell Viability
10%
Cell Size
10%
Oxidative Stress
10%
Pharmacology, Toxicology and Pharmaceutical Science
Reactive Oxygen Metabolite
100%
Methotrexate
100%
Cytotoxicity
20%
Cysteine
20%
Acetic Acid Derivative
20%
Rheumatoid Arthritis
20%
Lipocortin 5
20%
Cell Viability
10%
Anti-Inflammatory Drug
10%
Trypan Blue
10%
Immunosuppressive Agent
10%
Dihydrorhodamine 123
10%
Antioxidant
10%